Institut Pasteur Korea discusses strategies to expand cooperation with the HKU-Pasteur Research Pole

IPK’s first-in-class TB drug candidate is licensed out by Qurient to TB Alliance for further deve...

[Pasteur Network Job Opening] Regional Strategic Development Officer for the Pasteur Network: Asi...

[New Publication] IPK identified the potent antibacterial efficacy and new mechanism of action of...

Dr. Youngmee Jee visited France, including the Institut Pasteur in Paris, for a discussion o...

The IPK CEO presented the Infectious Disease Research Innovation Strategy at the 2022 EKC